Pivotal phase III trial of eniluracil in combination with fluorouracil and lecovorin in patients with metastatic breast cancer

Trial Profile

Pivotal phase III trial of eniluracil in combination with fluorouracil and lecovorin in patients with metastatic breast cancer

Planning
Phase of Trial: Phase III

Latest Information Update: 23 May 2013

At a glance

  • Drugs Eniluracil (Primary) ; Fluorouracil; Folinic acid
  • Indications Advanced breast cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 23 May 2013 The US FDA recommended that Adherex consider other larger clinical trial design alternatives for future development; Adherex is reviewing the feasibility of these and other clinical options.
    • 03 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top